Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous salivary gland stem cell transplantation after radiotherapy
NL-OMON49128Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous salivary gland stem cells in xerostomia and hyposalivation, sponsored by University Medical Center Groningen. Primary endpoints: Safety of autologous salivary gland stem cell transplantation and Feasibility based on submandibular salivary flow rate. Started Jun 2022; status: recruiting.
02
Drugs
autologous salivary gland stem cells
03
Conditions
xerostomiahyposalivation
Beyond the preview
Go deeper on NL-OMON49128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49128.